Then in 1976, in a double-blind randomized controlled trial, Rawles and Kenmure reported greater serum aspartate aminotransferase levels, indicating increased infarct size, in patients with acute myocardial infarction receiving high-flow oxygen compared with room air [ 13].
Clinically, hyperoxia is associated with negative outcomes such as acute lung injury [6], increased infarct size in patients with a myocardial or cerebral infarction [7, 8] and increased mortality in patients after cardiac arrest [9, 10].
In acute myocardial infarction, anemia may worsen myocardial ischemia, generate arrhythmias, and potentially increase infarct size [20].
In acute myocardial infarction, anemia may worsen myocardial ischemia, generate arrhythmias, and potentially increase infarct size [ 20].
In parallel, we observed a massive increase of the infarction size within the area at risk in PI3Kγ−/− hearts at the early stage of M I/R injury (assayed at 24 hours, Figure 1C E).
SU, on the other hand, have been reported to reduce myocardial blood flow, increase infarct size, and to increase early mortality after direct angioplasty for acute myocardial infarction.
The in vivo test indicated that 4c exhibited anti-myocardial ischemic effects featured by reducing infarction size and increasing the level of the intracellular enzymes detectable in serum.
When single vessels were clotted in the presence of fluoroacetate, the average infarction size at 24 hours was significantly increased to 5.19±0.28 µm2×105 (n = 3) compared to non-treated controls (Fig. 5A, E).
Defective microglial activation/proliferation significantly increased the size of infarction and the number of apoptotic neurons after stroke [ 34], which supports the pivotal role of microglia after ischemic stroke.
